Inventor · disambiguated record
Zhiliu Zhang
Also filed as: ZHANG ZHILIU
5 granted patents·3 pending applications·60 citations·filing 2010–2019
72Inventor score
Files withGLAXOSMITHKLINE IP DEV LTD4CHRISTENSEN IV SIEGFRIED BENJAMIN3QINGDAO HUANGHAI PHARMACEUTICAL CO LTD1
Top patents by PatentIndex Score
8 records- 0194US8937071B2Compounds as rearranged during transfection (RET) inhibitorsGLAXOSMITHKLINE IP DEV LTD·Filed 2014·Granted Jan 20, 2015·59 cites·15 claims
- 0269US9879021B2Compounds as rearranged during transfection (RET) inhibitorsGLAXOSMITHKLINE IP DEV LTD·Filed 2015·Granted Jan 30, 2018·1 cites·20 claims
- 0354US10294236B2Compounds as rearranged during transfection (RET) inhibitorsGLAXOSMITHKLINE IP DEV LTD·Filed 2017·Granted May 21, 2019·0 cites·19 claims
- 0445US11773078B2Furin inhibitorsGLAXOSMITHKLINE IP DEV LTD·Filed 2019·Granted Oct 3, 2023·0 cites·22 claims
- 0539US9809604B2DGAT1 inhibitor and preparation method and use thereofQINGDAO HUANGHAI PHARMACEUTICAL CO LTD·Filed 2014·Granted Nov 7, 2017·0 cites·20 claims
- 0626US2012083489A1Bis-pyridylpyridones as melanin-concentrating hormone receptor antagonistsCHRISTENSEN IV SIEGFRIED BENJAMIN·Filed 2010·Application pending·0 cites
- 0725US2012077795A1Bis-pyridylpyridones as melanin-concentrating hormone receptor 1 antagonistsCHRISTENSEN IV SIEGFRIED BENJAMIN·Filed 2010·Application pending·0 cites
- 0825US2012077794A1Bis-pyridylpyridones as melanin-concentrating hormone receptor 1 antagonistsCHRISTENSEN IV SIEGFRIED BENJAMIN·Filed 2010·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →